| Financial Year |
March 31 2023 |
| Monetary Funds |
246,508,841.42 |
| Held-for-trading Financial Assets |
367,881,099.86 |
| Notes Receivable |
1,579,004.48 |
| Accounts Receivable |
259,431,178.70 |
| Advances to Suppliers |
56,994,114.31 |
| Other Receivables |
4,005,365.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
217,970,080.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
116,900,247.11 |
| Total Current Assets |
1,356,161,363.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
195,260,881.24 |
| Under-construction Projects |
666,940,570.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,275,485.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,874,838.30 |
| Deferred Income Tax Assets |
4,024,355.70 |
| Other Non-Current Assets |
11,257,685.43 |
| Sub-Total of Non-Current Assets |
949,633,816.72 |
| Total Assets |
2,305,795,179.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
260,000,000.00 |
| Accounts Payable |
116,371,672.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,642,743.81 |
| Taxes Payable |
4,906,435.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,807,909.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
814,650.80 |
| Sub-Total of Current Liabilities |
415,809,956.80 |
| Long-term Loans |
-- |
| Bonds Payable |
502,868,016.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
514,260,496.24 |
| Total Liabilities |
930,070,453.04 |
| Paid-In Capital(Or Share Stock) |
417,750,916.00 |
| Capital Surplus |
242,308,748.07 |
| Surplus Reserve |
16,692,445.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
577,518,235.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,375,724,726.69 |
| Owner's Equity（Stockholder's Equity） |
1,375,724,726.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,305,795,179.73 |
